ABATA THERAPEUTICS
Abata Therapeutics is focused on translating the biology of regulatory t cells into transformational medicines for patients living with progressive multiple sclerosis and other severe autoimmune and inflammatory diseases. It is bringing an entirely new approach to the treatment of autoimmune disease by engineering tregs as targeted therapies that stop immune-mediated destruction and restore homeostasis.
ABATA THERAPEUTICS
Industry:
Biotechnology Medical Therapeutics
Founded:
2021-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.abatatx.com
Total Employee:
51+
Status:
Active
Total Funding:
95 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt WordPress Nginx Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Current Advisors List
Current Employees Featured
Founder
Investors List
Samsara BioCapital
Samsara BioCapital investment in Series A - Abata Therapeutics
JDRF T1D Fund
JDRF T1D Fund investment in Series A - Abata Therapeutics
Lightspeed Venture Partners
Lightspeed Venture Partners investment in Series A - Abata Therapeutics
Invus
Invus investment in Series A - Abata Therapeutics
ElevateBio
ElevateBio investment in Series A - Abata Therapeutics
Third Rock Ventures
Third Rock Ventures investment in Series A - Abata Therapeutics
Official Site Inspections
http://www.abatatx.com Semrush global rank: 5 M Semrush visits lastest month: 1.68 K
- Host name: 159.172.224.35.bc.googleusercontent.com
- IP address: 35.224.172.159
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Abata Therapeutics"
Who We Are - Abata Therapeutics
Who We Are. Abata was launched in 2021 by Third Rock Ventures with a $95 million Series A financing and brings together industry experts and deeply engaged pioneers in regulatory T …See details»
Abata Therapeutics - Crunchbase Company Profile
Abata Therapeutics is focused on translating the biology of regulatory t cells into transformational medicines for patients living with progressive multiple sclerosis and other severe autoimmune and inflammatory diseases.See details»
News and Press - T1D Fund: A Breakthrough T1D Venture
Aug 15, 2024 Please visit abatatx.com or follow us on ... the leading global T1D research and advocacy organization, we can exclusively focus on supporting innovative approaches and …See details»
Abata Therapeutics - LinkedIn
Abata Therapeutics is a clinical-stage biotech company dedicated to transforming lives with Treg therapies for severe autoimmune and inflammatory diseases.See details»
Our Programs - Abata Therapeutics
Abata is rapidly advancing its early programs with plans to initiate its first clinical study in 2024. Our initial pipeline includes our lead program for progressive multiple sclerosis (MS), as well as programs in Type 1 diabetes and two …See details»
Abata - Overview, News & Similar companies | ZoomInfo.com
Aug 24, 2023 Abata contact info: Phone number: (857) 230-0070 Website: www.abatatx.com What does Abata do? Abata was launched in 2021 by Third Rock Ventures with a $95 million …See details»
Abata Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Abatatx.com. Startups | Holding Company | 2021 | Massachusetts, United States | 10-50 | abatatx.com. Last update 11 Dec 2024. Overview. Pipeline. Deal. Translational Medicine. ...See details»
Abata Therapeutics - Inspiring Workplaces
Website: https://abatatx.com. 2024 Accolades. Submission highlights. This year’s strongest elements as indicated by our independent judges. Culture & Purpose; Comment from the …See details»
Abatatx.com Abata Therapeutics - HypeStat
• Abatatx.com ranks #7,695,708 globally on HypeStat. What percent of global Internet users visit Abatatx.com? • 1.3E-6% of global Internet users visit Abatatx.comSee details»
Abata Therapeutics Announces FDA Clearance of Investigational …
Jul 9, 2024 Please visit abatatx.com or follow us on ... the leading global T1D research and advocacy organization, we can exclusively focus on supporting innovative approaches and …See details»
is abatatx.com legitimate or a scam?
2 days ago abatatx.com Reviews is abatatx.com legitimate or a scam? Rank Status: 60 to 80 Report! Are you Scammed? Need help? Talk to an expert. ... Organization : Identity Protection …See details»
Samantha Singer, MBA - Abata Therapeutics
Nov 4, 2021 At Biogen, she also held leadership roles in organization effectiveness and global supply chain. Before Biogen, Samantha was a strategy consultant at the Boston Consulting …See details»
ABA-201 - Drug Targets, Indications, Patents - Synapse - Patsnap
ABA-201 aims to benefit patients with type 1 diabetes who have remaining beta cell function ABA-201 is currently in IND-enabling studies and on track to enter the clinic in 2025 Strategic …See details»
Abata Therapeutics Email Formats & Email Address Examples
Frequently Asked Questions What does Abata Therapeutics do? Abata Therapeutics was founded in 2021. The company's main headquarters is located in Watertown, MA 02472 US operates in …See details»
is ecode360.com legitimate or a scam? - scamminder.com
Dec 4, 2024 Ecode360 is a comprehensive online platform for hosting and accessing municipal codes and other legal documents. It provides a user-friendly interface for citizens, government …See details»
Join Us - Abata Therapeutics
“At Abata, we’re lucky to have a team of individuals from an incredibly diverse range of professional backgrounds. I’m inspired by the passion behind our science, which is rooted in …See details»
The Prata Organization of American Income
The Prata Organization of American Income. The Prata Organization of American Income ...See details»
Kelly Sitkin: Accelerating Progress for Brain Tumor Community as …
KS: Our strengths as an organization is our dedication to funding breakthrough research and the breadth and depth of our patient services program. The most impactful investment for brain …See details»
Abata Therapeutics Announces Strategic Investment from Bristol …
Aug 15, 2024 Equity investment reflects commitment to Treg science and support of Abata’s approach and programs. WATERTOWN, MA, August 15, 2024 – Abata Therapeutics, a …See details»
Our Approach - Abata Therapeutics
Use of the native TCR pathway uniquely maximizes the full effect of Tregs, helps to maintain a stable Treg phenotype for optimal safety and stimulates tissue residency for durability. TCRs …See details»